发明名称 New carboxamidothiazole derivatives are cholecystokinin agonists, useful in treatment of gastrointestinal and central nervous system diseases
摘要 Carboxamidothiazole derivatives (I), their salts and solvates, are new. Carboxamidothiazole derivatives of formula (I), their salts and solvates, are new. R1 = 2-(R4)-3-(R5)-4-(R6)-6-methoxy-phenyl; R2 = CH2-R7, (CH2)2-R7, S-CH2-R7, CH2-S-R7, or 5-8C alkyl; R3 = indol-2-yl of formula (i) or pyrrolo-pyridyl of formula (ii); one of X1, X2, X3, X4 is N and the others = CR14; R4 = H or MeO; R5 = H, Me, Et, i-Pr, MeO, EtO or halo; R6 = H, Me, Et, MeO or halo; or R5+R6 = methylenedioxy; provided that R4, R5, R6 do not all = H; R7 = 5-7C cycloalkyl (optionally substituted by one or two Me); R8 = (CH2)nR15 or -(CH2)m-Ph (ring substituted by R15) R9 = H or Me; R10-R13 = H, Me, Et, OH, acetyloxy, MeO, EtO, methylthio, CF3, amino or halo; R14 = H or MeO; R15 = COOH or COOR16; R16 = 1-4C alkyl; n = 1-5; m = 0 or 1. An Independent claim is included for the preparation of intermediates of formula (XVIII) comprising protecting the amine function of a compound of formula (XIX) with di-tert.-butyldicarbonate, followed by treatment of the resulting compound of formula (XX) with n-BuLi or sec-BuLi, condensing the lithiated derivative with an oxalic ester such as ethyl or benzyl oxalate, followed by saponification of the resulting ester of formula (XXI) in which A is an ethyl or hydrogenating the ester when A is benzyl. X1'- X4' = CH (optionally substituted by methyl); or one of X1'- X4' = N and the others are CR14; R14 = H or MeO.
申请公布号 FR2777887(A1) 申请公布日期 1999.10.29
申请号 FR19980005106 申请日期 1998.04.23
申请人 SANOFI 发明人 BIGNON ERIC;BOIGEGRAIN ROBERT;BRODIN ROGER;MOLIMARD JEAN CHARLES;OLLIERO DOMINIQUE
分类号 A61K31/425;C07D417/12;(IPC1-7):C07D417/12 主分类号 A61K31/425
代理机构 代理人
主权项
地址